Latest Financial Health News

Monadelphous Group Limited has announced a fully franked ordinary dividend of AUD 0.39 per share for the half-year ending June 2025, alongside a Dividend Reinvestment Plan offering shareholders a flexible way to reinvest.

RWC reported a 5.5% increase in FY25 net sales driven by the Holman acquisition, while adjusted EBITDA edged up 1.1% amid margin pressures. The company warns of tariff-related cost impacts in FY26, offset by ongoing cost savings and strategic adjustments.

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Audinate reported a 33% revenue decline in FY25 due to OEM inventory adjustments but boosted gross margins to 82.1% through a software shift and completed the strategic Iris acquisition, setting the stage for growth in FY26.

GWA Group Limited has launched a $30 million on-market share buyback program, balancing capital return with ongoing investment in growth. The move underscores management's confidence in the company’s financial strength and outlook.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

Fiducian Group Limited has reported a solid 23.5% rise in net profit for the 2025 financial year, alongside a 10.6% increase in revenue and a higher fully franked final dividend of 24.7 cents per share.

Bluescope Steel Limited has announced a final dividend of 30 cents per share, 50% franked, payable in October 2025. This dividend reflects the company’s steady financial position for the year ending June 2025.

Contact Energy Limited has announced a total dividend of NZD 0.2529 per share for the six months ending June 2025, including an ordinary and supplementary dividend, with a Dividend Reinvestment Plan available.

The a2 Milk Company reported a robust 13.5% revenue increase and a 21.1% rise in net profit for the fiscal year ending June 2025, alongside healthy dividend declarations.

NGE Capital Limited reported a steady half-year profit increase alongside a notable rise in net tangible assets per share, continuing its share buy-back program and initiating new investments.